A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Celldex Therapeutics
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Critical Outcome Technologies Inc.
Santa Maria Biotherapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)